Video

Why It’s Important to Be a Well-Educated, Proactive Patient

Author(s):

Patients with cancer can advocate for themselves by researching their illnesses and treatments before an appointment, so they’re able to ask better questions, says an expert from the HealthTree Foundation for Multiple Myeloma.

Patients with cancer often look for ways to empower themselves as they navigate the uncertainty of their cancer journey. According to Jenny Ahlstrom, who lives with multiple myeloma, one way to feel more empowered is to educate yourself on your disease as much as possible.

In an interview with CURE®, Ahlstrom, who launched the HealthTree Foundation for Multiple Myeloma, explained how doing proper research on your cancer type can lead to better outcomes.

“I feel like the work I've done has helped me and brought me a lot of joy in service of other patients,” Ahlstrom said. “But it's also empowered other people to ask better questions... You’re getting better outcomes when you educate yourself about your own disease. You will, because you'll ask better questions in your clinic.”

Transcription:

I think the idea that patients can make more of a difference than they've ever thought is a reality. I feel like the work I've done has helped me and brought me a lot of joy in service of other patients. But it's also empowered other people to ask better questions. They’re getting better outcomes.

You’re getting better outcomes when you educate yourself about your own disease. You will, because you'll ask better questions in your clinic. And you won’t ask basics like “What's a light chain” and your doctor has to spend 20 minutes explaining what a light chain is. (You can) go do that elsewhere, so you come into the office prepared, and then you can contribute.

So, I feel like we're inviting all these patients to contribute to a myeloma cure instead of sitting back and waiting for a myeloma cure. And I think patients can do that for any disease.

Editor's Note: Myeloma Crowd is now known as HealthTree Foundation for Multiple Myeloma.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of bald man.
Dr. Tycel Phillips is an Associate Professor in the Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope in Duarte, California.
Image of Dr. Salani.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.
Image of Dr. Fakih.
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Related Content